BioCentury
ARTICLE | Clinical News

Retroviral vector bearing the gene for glucocerebrosidase: Began a Phase I trial in five patients, who first received GM-CSF to increase production of their hem

October 30, 1995 8:00 AM UTC

Genzyme Corp. (GENZ), Cambridge, Mass. Product: Retroviral vector bearing the gene for glucocerebrosidase Indication: Gaucher disease Status: Began a Phase I trial in five patients, who first receive...